Gossamer Bio, Inc. SEC filings GOSS

Gossamer Bio, Inc. has 484 filings in SEC EDGAR's recent list, going back to Jan 19, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Apr 24, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Gossamer Bio, Inc. SEC filings
Form Description Filed Period
8-K Current report
Shareholder vote results
Oct 28, 2026 Oct 27, 2026
8-K Current report
Other events
Sep 28, 2026 Sep 25, 2026
8-K Current report
Other events
Sep 23, 2026 Sep 23, 2026
8-K Current report
Officer or director change
Sep 16, 2026 Sep 16, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Sep 11, 2026 Sep 10, 2026
8-K Current report
Other events
Sep 9, 2026 Sep 9, 2026
8-K Current report
Bylaw or fiscal year change
Sep 3, 2026 Sep 3, 2026
8-K Current report
Bylaw or fiscal year change
Aug 26, 2026 Aug 24, 2026
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
Aug 21, 2026 Aug 20, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Material agreement, Agreement ended, Results of operations, Regulation FD disclosure, Other events
Jul 27, 2026 Jul 23, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jul 15, 2026 Jul 14, 2026
8-K Current report
Regulation FD disclosure
Jul 1, 2026 Jul 1, 2026
8-K Current report
Regulation FD disclosure
Jun 17, 2026 Jun 17, 2026
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure
Jun 5, 2026 Jun 3, 2026
8-K Current report
Shareholder vote results
Jun 5, 2026 Jun 4, 2026
8-K Current report
Other events
Jun 2, 2026 Jun 2, 2026
8-K Current report
Material agreement, Results of operations, Officer or director change, Regulation FD disclosure, Other events
May 18, 2026 May 18, 2026
8-K Current report
Listing notice
Apr 9, 2026 Apr 8, 2026
8-K Current report
Results of operations
Mar 17, 2026 Mar 17, 2026
8-K Current report
Other events
Feb 23, 2026 Feb 23, 2026
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Unregistered share sale
Sep 25, 2025 Sep 24, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 25, 2025 Jun 25, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 16, 2025 Jun 16, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
8-K Current report
Results of operations
Mar 13, 2025 Mar 13, 2025
8-K Current report
Other events
Feb 19, 2025 Feb 19, 2025
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Listing notice
Sep 13, 2024 Sep 11, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
8-K Current report
Other events
Jul 18, 2024 Jul 18, 2024
8-K Current report
Shareholder vote results
Jun 10, 2024 Jun 6, 2024
8-K Current report
Listing notice
May 24, 2024 May 22, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
8-K Current report
Material agreement, Agreement ended, Unregistered share sale, Other events
May 6, 2024 May 3, 2024
8-K Current report
Officer or director change
Mar 12, 2024 Mar 11, 2024
8-K Current report
Results of operations
Mar 5, 2024 Mar 5, 2024
8-K Current report
Other events
Mar 4, 2024 Mar 4, 2024
8-K Current report
Officer or director change
Nov 29, 2023 Nov 28, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change
Nov 27, 2023 Nov 20, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Listing notice
Oct 20, 2023 Oct 19, 2023
8-K Current report
Officer or director change
Sep 7, 2023 Sep 6, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 20, 2023 Jul 19, 2023
8-K Current report
Other events
Jul 20, 2023 Jul 20, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 9, 2023 Jun 8, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Other events
Apr 3, 2023 Apr 3, 2023
8-K Current report
Results of operations
Mar 17, 2023 Mar 17, 2023
8-K Current report
Other events
Dec 6, 2022 Dec 6, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 13, 2022 Jul 13, 2022
8-K Current report
Shareholder vote results
Jun 10, 2022 Jun 9, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
8-K Current report
Results of operations, Other events
Apr 25, 2022 Apr 25, 2022
8-K Current report
Results of operations
Mar 3, 2022 Mar 3, 2022
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
8-K Current report
Regulation FD disclosure, Other events
Oct 12, 2021 Oct 11, 2021
8-K Current report
Officer or director change
Sep 21, 2021 Sep 16, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 14, 2021 Jun 9, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
8-K Current report
Officer or director change
Apr 20, 2021 Apr 17, 2021
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Officer or director change
Nov 17, 2020 Nov 16, 2020
8-K Current report
Results of operations
Nov 10, 2020 Nov 10, 2020
8-K Current report
Regulation FD disclosure, Other events
Oct 13, 2020 Oct 13, 2020
8-K Current report
Results of operations
Aug 11, 2020 Aug 11, 2020
8-K Current report
Material agreement, New debt
Jul 2, 2020 Jul 2, 2020
8-K Current report
Shareholder vote results
Jun 18, 2020 Jun 17, 2020
8-K Current report
Material agreement, New debt, Other events
May 21, 2020 May 18, 2020
8-K Current report
Results of operations
May 12, 2020 May 12, 2020
8-K Current report
Results of operations
Mar 24, 2020 Mar 24, 2020
8-K Current report
Regulation FD disclosure
Jan 13, 2020 Jan 13, 2020
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
8-K Current report
Officer or director change
Sep 13, 2019 Sep 12, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Shareholder vote results
Jun 11, 2019 Jun 10, 2019
8-K Current report
Officer or director change
May 30, 2019 May 30, 2019
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2019 May 14, 2019
8-K Current report
Material agreement, New debt
May 3, 2019 May 2, 2019
8-K Current report
Results of operations
Mar 22, 2019 Mar 22, 2019
8-K Current report
Officer or director change
Mar 11, 2019 Mar 7, 2019
8-K Current report
Bylaw or fiscal year change
Feb 12, 2019 Feb 12, 2019

Showing 88 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GOSS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1728117

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.